Skip to main content

Table 2 Odds ratio (OR) and 95% confidence intervals (CIs) for anxiety across the quintuples (Q) of energy-adjusted dietary fatty acid intake

From: Higher dietary fat quality is associated with lower anxiety score in women: a cross-sectional study

 Q1
(n = 60)
Q2
(n = 60)
Q3
(n = 60)
Q4
(n = 60)
Q5
(n = 60)
p-trend
Total fat (non-case/case)(43/17)(39/21)(35/25)(32/28)(38/22) 
Model 11.001.36 (0.62–2.94)1.80 (0.84–3.86)2.21 (1.03–4.71)1.46 (0.67–3.15)0.1
P-value 0.40.10.10.4 
Model 21.001.23 (0.55–2.73)1.77 (0.79–3.96)1.81 (0.82–3.98)1.20 (0.56–2.66)0.4
P-value 0.60.10.10.6 
SFAs (non-case/case)(44/16)(43/17)(35/25)(37/23)(28/32) 
Model 11.001.08 (0.48–2.42)1.96 (0.91–4.23)1.66 (0.76–3.60)3.25 (1.51–7.02)0.001
P-value 0.840.080.10.003 
Model 3: model 2 + MUFAs, PUFAs, Trans1.001.36 (0.59–3.12)2.12 (0.96–4.69)1.66 (0.75–3.70)3.17 (1.43–7.00)0.005
P-value 0.40.060.20.004 
MUFAs (non-case/case)(29/31)(38/22)(39/21)(39/22)(42/17) 
Model 11.000.54 (0.26–1.12)0.50 (0.24–1.04)0.52 (0.25–1.09)0.37 (0.17–0.80)0.02
P-value 0.60.60.020.2 
Model 4: model 2 + SFAs, PUFAs, Trans1.000.41 (0.19–0.90)0.36 (0.16–0.82)0.34 (0.15–0.77)0.15 (0.05–0.44)0.001
P-value 0.020.010.010.001 
Oleic acid (non-case/case)(25/35)(38/22)(40/20)(41/19)(43/17) 
Model 11.000.42 (0.20–0.88)0.34 (0.16–0.73)0.33 (0.15–0.69)0.28 (0.13–0.60)0.001
P-value 0.020.0050.0040.001 
Model 4: model 2 + SFAs, PUFAs, Trans1.000.43 (0.20–0.92)0.33 (0.15–0.72)0.28 (0.12–0.64)0.25 (0.09–0.67)0.002
P-value 0.030.0060.0020.006 
PUFAs (non-case/case)(32/28)(39/21)(44/16)(30/30)(42/18) 
Model 11.000.61 (0.29–1.28)0.41 (0.19–0.89)1.14 (0.55–2.34)0.49 (0.23–1.03)0.3
P-value 0.10.020.70.06 
Model 5: model 2 + SFAs, MUFAs, Trans1.000.96 (0.41–2.23)1.71 (0.72–4.05)2.35 (0.99–5.58)1.49 (0.53–4.14)0.1
P-value 0.90.20.0520.4 
Dietary cholesterol (non-case/case)(42/18)(34/26)(41/19)(38/22)(32/28) 
Model 11.001.78 (0.84–3.78)1.08 (0.49–2.34)1.35 (0.63–2.89)2.04 (0.96–4.32)0.1
P-value 0.10.80.40.06 
Model 6: model 2 + SFAs, PUFAs, MUFAs, Trans1.001.91 (0.83–4.41)0.92 (0.38–2.22)0.93 (0.38–2.20)0.98 (0.39–2.50)0.4
P-value 0.20.50.60.7 
n-3 PUFAs (non-case/case)(36/24)(35/25)(47/13)(32/28)(37/23) 
Model 11.001.07 (0.51–2.21)0.41 (0.18–0.92)1.31 (0.63–2.70)0.93 (0.44–1.94)0.9
P-value 0.80.030.40.8 
Model 7: model 2 + SFAs, MUFAs, Trans, n-61.001.05 (0.46–2.40)0.37 (0.15–0.94)0.92 (0.38–2.26)0.66 (0.21–2.04)0.4
P-value 0.80.030.80.4 
ALA (non-case/case)(24/36)(35/25)(28/32)(46/14)(54/6) 
Model 11.000.44 (0.21–0.92)0.73 (0.35–1.51)0.18 (0.08–0.40)0.08 (0.03–0.21) < 0.001
P-value 0.020.3 < 0.001 < 0.001 
Model 7: model 2 + SFAs, MUFAs, Trans, n-61.000.34 (0.15–0.79)0.59 (0.25–1.39)0.14 (0.05–0.37)0.07 (0.02–0.23) < 0.001
P-value 0.60.60.1 < 0.001 
DHA (non-case/case)(34/26)(38/22)(39/21)(32/28)(44/16) 
Model 11.000.75 (0.36–1.57)0.70 (0.33–1.47)1.14 (0.55–2.35)0.47 (0.22–1.02)0.2
P-value 0.40.30.70.05 
Model 7: model 2 + SFAs, MUFAs, Trans, n-61.000.77 (0.34–1.73)0.94 (0.41–2.15)1.29 (0.57–2.90)0.59 (0.25–1.40)0.6
P-value 0.50.80.50.2 
EPA (non-case/case)(33/27)(39/21)(37/23)(36/24)(42/18) 
Model 11.000.65 (0.31–1.37)0.76 (0.36–1.57)0.81 (0.39–1.68)0.52 (0.24–1.11)0.2
P-value 0.20.40.50.09 
Model 7: model 2 + SFAs, MUFAs, Trans, n-61.000.63 (0.27–1.44)0.93 (0.41–2.12)0.78 (0.35–1.75)0.62 (0.26–1.48)0.4
P-value 0.20.80.50.2 
n-6 PUFAs (non-case/case)(40/20)(40/20)(35/25)(34/26)(38/22) 
Model 11.001.00 (0.46–2.13)1.42 (0.68–3.00)1.52 (0.72–3.20)1.15 (0.54–2.45)0.4
P-value 1.00.30.20.7 
Model 8: model 2 + SFAs, MUFAs, Trans, n-31.000.89 (0.37–2.10)1.56 (0.65–3.71)1.61 (0.65–4.00)1.24 (0.38–4.08)0.3
P-value 0.70.30.20.7 
n-3: n-6 (non-case/case)(34/26)(33/27)(33/27)(47/13)(40/20) 
Model 11.001.07 (0.5–2.2)1.07 (0.5–2.2)0.3 (0.16–0.80)0.6 (0.31–1.37)0.02
P-value 0.850.850.010.26 
Model 5: model 2 + SFAs, MUFAs, Trans1.000.97 (0.42–2.23)0.94 (0.41–2.17)0.36 (0.15–0.88)0.56 (0.24–1.03)0.02
P-value 0.90.90.020.1 
  1. Model 1: Crude
  2. Model 2 Adjusted for age, physical activity, total energy intake, job, body mass index, and parity
  3. SFAs saturated fatty acids, MUFAs monounsaturated fatty acids, PUFAs polyunsaturated fatty acids, ALA alpha-linolenic acid, DHA docosahexaenoic acid, EPA eicosapentaenoic acids